Loading clinical trials...
Loading clinical trials...
Selective cannulation of common bile duct (CBD) by insertion of a guide-wire seems to be associated with fewer complications and post-ERCP (Endoscopic retrograde cholangiopancreatography) pancreatitis (PEP) rate than the conventional biliary tree access with cannulotome (CT-25 Cook Medical) with contrast injection even if results are conflicting. the aim of our study is to test a new guide-wire (loop-tip wire), with a loop in the tip, for the prevention of PEP and biliary tree access, in PEP high-risk patients.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
San Paolo Hospital
Milan, Italy, Italy
Start Date
October 1, 2010
Primary Completion Date
February 1, 2013
Completion Date
January 1, 2014
Last Updated
January 18, 2013
320
ESTIMATED participants
Loop-tip wire (Cook Medical) for the cannulation of the CBD
DEVICE
Cannulotome CT-25mm Cook Medical
DEVICE
Lead Sponsor
Hospital San Paolo
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions